Selegiline in Parkinson's disease
Identifieur interne : 001367 ( Istex/Corpus ); précédent : 001366; suivant : 001368Selegiline in Parkinson's disease
Auteurs : Donald B. CalneSource :
- BMJ [ 0959-8138 ] ; 1995-12-16.
Url:
DOI: 10.1136/bmj.311.7020.1583
Links to Exploration step
ISTEX:A95255DFB34A7B74659570F2016CF55D8B783866Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Selegiline in Parkinson's disease</title><author wicri:is="90%"><name sortKey="Calne, Donald B" sort="Calne, Donald B" uniqKey="Calne D" first="Donald B" last="Calne">Donald B. Calne</name><affiliation><mods:affiliation>Director Neurodegenerative Disorders Centre, Faculty of Medicine, Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada V6T 2B5</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:A95255DFB34A7B74659570F2016CF55D8B783866</idno><date when="1995" year="1995">1995</date><idno type="doi">10.1136/bmj.311.7020.1583</idno><idno type="url">https://api-v5.istex.fr/document/A95255DFB34A7B74659570F2016CF55D8B783866/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001367</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001367</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Selegiline in Parkinson's disease</title><author wicri:is="90%"><name sortKey="Calne, Donald B" sort="Calne, Donald B" uniqKey="Calne D" first="Donald B" last="Calne">Donald B. Calne</name><affiliation><mods:affiliation>Director Neurodegenerative Disorders Centre, Faculty of Medicine, Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada V6T 2B5</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">BMJ</title><title level="j" type="abbrev">BMJ</title><idno type="ISSN">0959-8138</idno><idno type="eISSN">1468-5833</idno><imprint><publisher>British Medical Journal Publishing Group</publisher><date type="published" when="1995-12-16">1995-12-16</date><biblScope unit="volume">311</biblScope><biblScope unit="issue">7020</biblScope><biblScope unit="page" from="1583">1583</biblScope></imprint><idno type="ISSN">0959-8138</idno></series><idno type="istex">A95255DFB34A7B74659570F2016CF55D8B783866</idno><idno type="DOI">10.1136/bmj.311.7020.1583</idno><idno type="href">bmj-311-1583.pdf</idno><idno type="PMID">8555790</idno><idno type="local">bmj;311/7020/1583</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0959-8138</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><istex><corpusName>bmj</corpusName><author><json:item><name>Donald B Calne</name><affiliations><json:string>Director Neurodegenerative Disorders Centre, Faculty of Medicine, Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada V6T 2B5</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Therapeutic trials</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Epidemiologic studies</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Brain stem / cerebellum</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Drugs: CNS (not psychiatric)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Stroke</value></json:item></subject><language><json:string>eng</json:string></language><originalGenre><json:string>editorial</json:string></originalGenre><qualityIndicators><score>1.743</score><pdfWordCount>1731</pdfWordCount><pdfCharCount>10933</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>2</pdfPageCount><pdfPageSize>595.27 x 841.89 pts (A4)</pdfPageSize><refBibsNative>false</refBibsNative><abstractWordCount>1</abstractWordCount><abstractCharCount>0</abstractCharCount><keywordCount>6</keywordCount></qualityIndicators><title>Selegiline in Parkinson's disease</title><pmid><json:string>8555790</json:string></pmid><genre><json:string>editorial</json:string></genre><host><title>BMJ</title><language><json:string>unknown</json:string></language><issn><json:string>0959-8138</json:string></issn><eissn><json:string>1468-5833</json:string></eissn><publisherId><json:string>BMJ</json:string></publisherId><volume>311</volume><issue>7020</issue><pages><first>1583</first><total>2</total></pages><genre><json:string>journal</json:string></genre></host><categories><wos></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>general & internal medicine</json:string></scienceMetrix></categories><publicationDate>1995</publicationDate><copyrightDate>1995</copyrightDate><doi><json:string>10.1136/bmj.311.7020.1583</json:string></doi><id>A95255DFB34A7B74659570F2016CF55D8B783866</id><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api-v5.istex.fr/document/A95255DFB34A7B74659570F2016CF55D8B783866/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api-v5.istex.fr/document/A95255DFB34A7B74659570F2016CF55D8B783866/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api-v5.istex.fr/document/A95255DFB34A7B74659570F2016CF55D8B783866/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Selegiline in Parkinson's disease</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>British Medical Journal Publishing Group</publisher><availability><p>© 1995 BMJ Publishing Group Ltd.</p></availability><date>1995-12-16</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Selegiline in Parkinson's disease</title><author xml:id="author-1"><persName><forename type="first">Donald B</forename><surname>Calne</surname></persName><affiliation>Director Neurodegenerative Disorders Centre, Faculty of Medicine, Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada V6T 2B5</affiliation></author></analytic><monogr><title level="j">BMJ</title><title level="j" type="abbrev">BMJ</title><idno type="pISSN">0959-8138</idno><idno type="eISSN">1468-5833</idno><imprint><publisher>British Medical Journal Publishing Group</publisher><date type="published" when="1995-12-16"></date><biblScope unit="volume">311</biblScope><biblScope unit="issue">7020</biblScope><biblScope unit="page" from="1583">1583</biblScope></imprint></monogr><idno type="istex">A95255DFB34A7B74659570F2016CF55D8B783866</idno><idno type="DOI">10.1136/bmj.311.7020.1583</idno><idno type="href">bmj-311-1583.pdf</idno><idno type="PMID">8555790</idno><idno type="local">bmj;311/7020/1583</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1995-12-16</date></creation><langUsage><language ident="en">en</language></langUsage><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Therapeutic trials</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Epidemiologic studies</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Brain stem / cerebellum</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Drugs: CNS (not psychiatric)</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Parkinson's disease</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Stroke</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1995-12-16">Created</change><change when="1995-12-16">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api-v5.istex.fr/document/A95255DFB34A7B74659570F2016CF55D8B783866/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="editorial" xml:lang="en"><front><journal-meta><journal-id journal-id-type="hwp">bmj</journal-id><journal-id journal-id-type="nlm-ta">BMJ</journal-id><journal-id journal-id-type="publisher-id">BMJ</journal-id><journal-title>BMJ</journal-title><abbrev-journal-title abbrev-type="publisher">BMJ</abbrev-journal-title><abbrev-journal-title abbrev-type="pubmed">BMJ</abbrev-journal-title><issn pub-type="ppub">0959-8138</issn><issn pub-type="epub">1468-5833</issn><publisher><publisher-name>British Medical Journal Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="other">bmj;311/7020/1583</article-id><article-id pub-id-type="pmid">8555790</article-id><article-id pub-id-type="other">1583</article-id><article-id pub-id-type="other">311/7020/1583</article-id><article-id pub-id-type="doi">10.1136/bmj.311.7020.1583</article-id><article-categories><subj-group subj-group-type="heading"><subject content-type="original">Editorials</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Therapeutic trials</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Epidemiologic studies</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Brain stem / cerebellum</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Drugs: CNS (not psychiatric)</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Parkinson's disease</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Stroke</subject></subj-group></article-categories><title-group><article-title>Selegiline in Parkinson's disease</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Calne</surname><given-names>Donald B</given-names></name></contrib></contrib-group><aff>Director Neurodegenerative Disorders Centre, Faculty of Medicine, Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada V6T 2B5 </aff><pub-date pub-type="ppub"><day>16</day><month>12</month><year>1995</year></pub-date><pub-date pub-type="epub"><day>16</day><month>12</month><year>1995</year></pub-date><volume>311</volume><volume-id pub-id-type="other">311</volume-id><volume-id pub-id-type="other">311</volume-id><issue>7020</issue><issue-id pub-id-type="other">bmj;311/7020</issue-id><issue-id pub-id-type="other">7020</issue-id><issue-id pub-id-type="other">311/7020</issue-id><fpage>1583</fpage><permissions><copyright-statement>© 1995 BMJ Publishing Group Ltd.</copyright-statement><copyright-year>1995</copyright-year></permissions><self-uri content-type="pdf" xlink:role="full-text" xlink:href="bmj-311-1583.pdf"></self-uri><counts><page-count count="2"></page-count></counts></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Selegiline in Parkinson's disease</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Selegiline in Parkinson's disease</title></titleInfo><name type="personal"><namePart type="given">Donald B</namePart><namePart type="family">Calne</namePart><affiliation>Director Neurodegenerative Disorders Centre, Faculty of Medicine, Vancouver Hospital and Health Sciences Centre, Vancouver, BC, Canada V6T 2B5</affiliation></name><typeOfResource>text</typeOfResource><genre type="editorial" displayLabel="editorial"></genre><subject><genre>hwp-journal-coll</genre><topic>Therapeutic trials</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Epidemiologic studies</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Brain stem / cerebellum</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Drugs: CNS (not psychiatric)</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Parkinson's disease</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Stroke</topic></subject><originInfo><publisher>British Medical Journal Publishing Group</publisher><dateIssued encoding="w3cdtf">1995-12-16</dateIssued><dateCreated encoding="w3cdtf">1995-12-16</dateCreated><copyrightDate encoding="w3cdtf">1995</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><relatedItem type="host"><titleInfo><title>BMJ</title></titleInfo><titleInfo type="abbreviated"><title>BMJ</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">0959-8138</identifier><identifier type="eISSN">1468-5833</identifier><identifier type="PublisherID">BMJ</identifier><identifier type="PublisherID-hwp">bmj</identifier><identifier type="PublisherID-nlm-ta">BMJ</identifier><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>311</number></detail><detail type="issue"><caption>no.</caption><number>7020</number></detail><extent unit="pages"><start>1583</start><total>2</total></extent></part></relatedItem><identifier type="istex">A95255DFB34A7B74659570F2016CF55D8B783866</identifier><identifier type="DOI">10.1136/bmj.311.7020.1583</identifier><identifier type="href">bmj-311-1583.pdf</identifier><identifier type="PMID">8555790</identifier><identifier type="local">bmj;311/7020/1583</identifier><accessCondition type="use and reproduction" contentType="copyright">© 1995 BMJ Publishing Group Ltd.</accessCondition><recordInfo><recordContentSource>BMJ</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001367 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001367 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:A95255DFB34A7B74659570F2016CF55D8B783866
|texte= Selegiline in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.29. |  |